CAMBRIDGE, Mass.–(BUSINESS WIRE)– #ArtificialIntelligence–Quantori has been named a Major Contender in Everest Group’s Pharmaceutical R&D IT Services PEAK Matrix® Assessment 2026 … […]
WILMINGTON, Mass.–(BUSINESS WIRE)—- $CRL #CDMO–Charles River Laboratories International, Inc. (NYSE: CRL) and Magellan Stem Cells, a private Australian biotech and cell-therapy firm, announce their collaboration to support Magellan in the development and clinical advancement of its proprietary stem cell-based therapies and regenerative medicine solutions. The partnership will leverage Charles River’s… … […]
New research from HomeExchange and Ipsos BVA finds nearly two-thirds of Americans trust others less than they did a decade ago and identifies what it could take to reverse the trend. CAMBRIDGE, Mass., Oct. 13, 2026 /PRNewswire/ — The United States stands out in the inaugural HomeExchange… … […]
The German pharmaceutical giant is consolidating its investment leadership at a new Cambridge office. … […]
A new approach can program these cells inside the body and shows promise against diseases caused by dysfunctional T cells, including lymphoma and autoimmune hepatitis. … […]
Associate Professor David Des Marais studies how plants interact with their surroundings and adapt over time. … […]
Caribou has halted trials of vispacabtagene regedleucel (vispa-cel, formerly CB-010) a treatment for relapsed or refractory B cell non-Hodgkin lymphoma; and of CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of patients with r/r multiple myeloma. The post StockWatch: Caribou Plunges as It Pursues Strategic Alternatives appeared… … […]
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced two presentations of data for STK-002 at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting, taking place October 9-12 in New Orleans. STK-002 represents… … […]
ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the U.S. full market release of Omnipod Discover™, a web-based data platform designed for Omnipod 5 users, their caregivers, and healthcare providers (HCPs). Omnipod Discover turns critical diabetes… … […]
LEXINGTON, Mass.–(BUSINESS WIRE)–FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced the launch of Synapse® Pathology v3.0. Featuring more than 50 new features and functions, Synapse Pathology v3.0 is designed to enhance the user experience while expanding the platform’s artificial intelligence (AI) capabilities to… … […]
Copyright © 2026 Biotech Networks, LLC
